This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

199 results

TWINRIX

Hepatitis A (inactivated) and hepatitis B (rDNA)(HAB) vaccine (adsorbed) <br> Vaccines

Uncovering patient symptoms

How well-controlled is asthma in your patients? Emerging evidence suggests that people may not always report symptoms to their physician, perhaps because they have learned to live with them.

RELVAR ELLIPTA

fluticasone furoate/vilanterol <br> Respiratory

Safety

Relvar Ellipta summary of safety – including information about active components

Relvar Dosage & Administration

Relvar Ellipta dosing and administration information – including information on the Ellipta inhaler and dose adjustments

Relvar FAQs

Frequently asked questions on Relvar Ellipta for asthma and COPD

COMBODART

Dutasteride/tamsulosin <br> Urology

VARILRIX

Varicella-zoster virus vaccine (live attenuated) <br> Vaccines

Zinnat Dosing & administration

Zinnat® (cefuroxime axetil) dosing and administration information designed to help healthcare professionals in their daily practice

ZINNAT

Cefuroxime axetil <br> Anti-infectives

Zinnat Safety

Information regarding the safety and tolerability of Zinnat® (cefuroxime axetil).

Zinnat Efficacy

A comprehensive source of information on the efficacy of Zinnat® (cefuroxime axetil), designed to help healthcare professionals in their daily practice

Zinnat Indication

Zinnat® (cefuroxime axetil) is indicated for a wide range of infections. This comprehensive information is designed to help healthcare professionals in daily practice.

Optimising the management of patients with acne

Overview of how effective management of patients with acne can help improve outcomes

Goals of therapy

An overview of common treatment goals and managing expectations according to their needs and concerns

In consultation guide

Overview of important considerations when talking to patients with acne and how a good patient-physician relationship can help contribute to treatment success

How to prescribe Duac Once Daily 5% Gel

An overview of Duac Prescribing Information

The role of Duac in the treatment of acne

Overview of Duac indication, components, strengths available and what patients can expect from treatment

Pharmacy consultation guide

Overview of the role of the pharmacist and objectives for consultations with acne patients

Pharmacy guide

Overview of the management of acne in the pharmacy setting

Understanding the needs of acne patients

Overview of acne and the needs of patients presenting in the pharmacy setting

Pharmacy Questions and Answers

Q and A for pharmacists

Acne treatment and skincare

Overview of the assessment acne, appropriate OTC and prescription acne treatments, managing treatment expectations and skincare routines

Duac MOA

MOA of Duac (clindamycin + BPO) and how two the components reduce antibiotic resistance

DUAC

Benzoyl peroxide/clindamycin phosphate <br> Dermatology

Impact on patients

Impact on patients

Mechanism of Action

Bexsero Mechanism of Action

Dosing and administration

Bexsero Dosing and Administration Information

Overview

An overview of Bexsero and supporting information

Patient Support

Contains tools for HCP to support patients.

Immunogenicity

Bexsero immunogenicity information

Prevention for invasive meningococcal disease (IMD)

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

Who is at risk of invasive meningococcal disease (IMD)

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

Zoom on MenB

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero, MenB

Symptoms of invasive meningococcal disease (IMD)

Invasive Meningococcal Disease, IMD, Neisseria, Bexsero

BEXSERO

Meningococcal group B vaccine (rDNA, component, adsorbed)<br/> Vaccines

Safety

Bexsero safety information

HCP Resource Center

Clinical resources for Health Care Professionals

SYNFLORIX

Pneumococcal polysaccharide conjugate vaccine (adsorbed) <br> Vaccines

Augmentin

Amoxicillin-clavulanate<br/> Anti-infectives

ROTARIX

Rotavirus vaccine (live, attenuated) <br> Vaccines

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

show more